BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31773268)

  • 1. Early-life Pb exposure as a potential risk factor for Alzheimer's disease: are there hazards for the Mexican population?
    Chin-Chan M; Cobos-Puc L; Alvarado-Cruz I; Bayar M; Ermolaeva M
    J Biol Inorg Chem; 2019 Dec; 24(8):1285-1303. PubMed ID: 31773268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early life exposure to lead (Pb) and changes in DNA methylation: relevance to Alzheimer's disease.
    Bihaqi SW
    Rev Environ Health; 2019 Jun; 34(2):187-195. PubMed ID: 30710487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD.
    Wu J; Basha MR; Brock B; Cox DP; Cardozo-Pelaez F; McPherson CA; Harry J; Rice DC; Maloney B; Chen D; Lahiri DK; Zawia NH
    J Neurosci; 2008 Jan; 28(1):3-9. PubMed ID: 18171917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease biomarkers and epigenetic intermediates following exposure to Pb in vitro.
    Bihaqi SW; Zawia NH
    Curr Alzheimer Res; 2012 Jun; 9(5):555-62. PubMed ID: 22272629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Phosphorylated Tau in Cerebrospinal Fluid is a Marker of Alzheimer's Disease Continuum in Young Urbanites Exposed to Air Pollution.
    Calderón-Garcidueñas L; Mukherjee PS; Waniek K; Holzer M; Chao CK; Thompson C; Ruiz-Ramos R; Calderón-Garcidueñas A; Franco-Lira M; Reynoso-Robles R; Gónzalez-Maciel A; Lachmann I
    J Alzheimers Dis; 2018; 66(4):1437-1451. PubMed ID: 30412505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formaldehyde, Epigenetics, and Alzheimer's Disease.
    Wang F; Chen D; Wu P; Klein C; Jin C
    Chem Res Toxicol; 2019 May; 32(5):820-830. PubMed ID: 30964647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone acetylation maps in aged mice developmentally exposed to lead: epigenetic drift and Alzheimer-related genes.
    Eid A; Bihaqi SW; Hemme C; Gaspar JM; Hart RP; Zawia NH
    Epigenomics; 2018 May; 10(5):573-583. PubMed ID: 29722544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The environment, epigenetics and amyloidogenesis.
    Wu J; Basha MR; Zawia NH
    J Mol Neurosci; 2008; 34(1):1-7. PubMed ID: 18157652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics, oxidative stress, and Alzheimer disease.
    Zawia NH; Lahiri DK; Cardozo-Pelaez F
    Free Radic Biol Med; 2009 May; 46(9):1241-9. PubMed ID: 19245828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation.
    Huat TJ; Camats-Perna J; Newcombe EA; Valmas N; Kitazawa M; Medeiros R
    J Mol Biol; 2019 Apr; 431(9):1843-1868. PubMed ID: 30664867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced repressive epigenetic marks, increased DNA damage and Alzheimer's disease hallmarks in the brain of humans and mice exposed to particulate urban air pollution.
    Calderón-Garcidueñas L; Herrera-Soto A; Jury N; Maher BA; González-Maciel A; Reynoso-Robles R; Ruiz-Rudolph P; van Zundert B; Varela-Nallar L
    Environ Res; 2020 Apr; 183():109226. PubMed ID: 32045727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulons in Alzheimer's disease.
    Raval M; Mishra S; Tiwari AK
    Prog Mol Biol Transl Sci; 2023; 198():185-247. PubMed ID: 37225321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics.
    Bakulski KM; Rozek LS; Dolinoy DC; Paulson HL; Hu H
    Curr Alzheimer Res; 2012 Jun; 9(5):563-73. PubMed ID: 22272628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics in Alzheimer's disease: a focus on DNA modifications.
    Coppieters N; Dragunow M
    Curr Pharm Des; 2011; 17(31):3398-412. PubMed ID: 21902668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic noise exposure and Alzheimer disease: Is there an etiological association?
    Cui B; Li K
    Med Hypotheses; 2013 Oct; 81(4):623-6. PubMed ID: 23899629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothermia and Alzheimer's disease neuropathogenic pathways.
    Whittington RA; Papon MA; Chouinard F; Planel E
    Curr Alzheimer Res; 2010 Dec; 7(8):717-25. PubMed ID: 20678067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpesviral infections and antimicrobial protection for Alzheimer's disease: Implications for prevention and treatment.
    Qin Q; Li Y
    J Med Virol; 2019 Aug; 91(8):1368-1377. PubMed ID: 30997676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations.
    Li K; Wei Q; Liu FF; Hu F; Xie AJ; Zhu LQ; Liu D
    Mol Neurobiol; 2018 Apr; 55(4):3021-3032. PubMed ID: 28456942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.